C
Charlotta Roos
Researcher at Lund University
Publications - 7
Citations - 2931
Charlotta Roos is an academic researcher from Lund University. The author has contributed to research in topics: Cholesterol & Glucokinase regulatory protein. The author has an hindex of 6, co-authored 7 publications receiving 2760 citations. Previous affiliations of Charlotta Roos include University of Oxford.
Papers
More filters
Journal ArticleDOI
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
Sekar Kathiresan,Sekar Kathiresan,Olle Melander,Candace Guiducci,Aarti Surti,Noël P. Burtt,Mark J. Rieder,Gregory M. Cooper,Charlotta Roos,Benjamin F. Voight,Benjamin F. Voight,Aki S. Havulinna,Björn Wahlstrand,Thomas Hedner,Dolores Corella,E. Shyong Tai,Jose M. Ordovas,Göran Berglund,Erkki Vartiainen,Pekka Jousilahti,Bo Hedblad,Marja-Riitta Taskinen,Christopher Newton-Cheh,Christopher Newton-Cheh,Veikko Salomaa,Leena Peltonen,Leif Groop,Leif Groop,David Altshuler,Marju Orho-Melander +29 more
TL;DR: Using genome-wide association data from three studies and targeted replication association analyses in up to 18,554 independent participants, it is shown that common SNPs at 18 loci are reproducibly associated with concentrations of low-density cholesterol, high-density lipoprotein (HDL) cholesterol, and/or triglycerides.
Journal ArticleDOI
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
Sekar Kathiresan,Olle Melander,Dragi Anevski,Candace Guiducci,Noël P. Burtt,Charlotta Roos,Joel N. Hirschhorn,Göran Berglund,Bo Hedblad,Leif Groop,David Altshuler,Christopher Newton-Cheh,Marju Orho-Melander +12 more
TL;DR: A genotype score of nine validated SNPs that are associated with modulation in levels of LDL or HDL cholesterol was an independent risk factor for incident cardiovascular disease.
Journal ArticleDOI
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
Nicola L. Beer,N. D. Tribble,Laura J. McCulloch,Charlotta Roos,Charlotta Roos,Paul Johnson,Marju Orho-Melander,Anna L. Gloyn +7 more
TL;DR: Altered GCK regulation in liver is predicted to enhance glycolytic flux, promoting hepatic glucose metabolism and elevating concentrations of malonyl-CoA, a substrate for de novo lipogenesis, providing a mutational mechanism for the reported association of this variant with raised triglycerides and lower glucose levels.
Journal ArticleDOI
Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations
Marju Orho-Melander,Olle Melander,Candace Guiducci,Pablo Perez-Martinez,Pablo Perez-Martinez,Dolores Corella,Charlotta Roos,Ryan Tewhey,Mark J. Rieder,Jennifer L. Hall,Gonçalo R. Abecasis,E. Shyong Tai,Cullan Welch,Donna K. Arnett,Valeriya Lyssenko,Eero Lindholm,Richa Saxena,Paul I.W. de Bakker,Noël P. Burtt,Benjamin F. Voight,Joel N. Hirschhorn,Katherine L. Tucker,Thomas Hedner,Tiinamaija Tuomi,Bo Isomaa,Karl-Fredrik Eriksson,Marja-Riitta Taskinen,Björn Wahlstrand,Thomas Edward Hughes,Laurence D. Parnell,Chao-Qiang Lai,Göran Berglund,Leena Peltonen,Erkki Vartiainen,Pekka Jousilahti,Aki S. Havulinna,Veikko Salomaa,Peter M. Nilsson,Leif Groop,Leif Groop,David Altshuler,Jose M. Ordovas,Sekar Kathiresan +42 more
TL;DR: These findings point to a molecular mechanism in humans by which higher triglycerides and CRP can be coupled with lower plasma glucose concentrations and position GCKR in central pathways regulating both hepatic triglyceride and glucose metabolism.
Journal ArticleDOI
Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity
Emily Sonestedt,Charlotta Roos,Bo Gullberg,Ulrika Ericson,Elisabet Wirfält,Marju Orho-Melander +5 more
TL;DR: The results indicate that high-fat diets and low physical activity levels may accentuate the susceptibility to obesity by the FTO variant.